Review
-
The clinical impact of precise assessment of predictive biomarkers in gastroesophageal cancer: focus on the PD-L1 combined positive score (CPS) and tumor area positivity (TAP) systems
-
Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2− metastatic breast cancer
-
Clinicopathological and molecular perspectives on thoracic SMARCA4-deficient undifferentiated tumors and SMARCA4-deficient non-small cell lung carcinomas
-
Invasiveness or growth pattern in urothelial tumours. A perspective to rethink the current WHO classification
-
Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapy
-
Clinical needs and pathology’s answers in neuroendocrine neoplasms of the lung
-
From dominance to decline: can we reverse the trend in small molecule and TKI cancer therapies?
-
The oral microbiome and its role in oral squamous cell carcinoma: a systematic review of microbial alterations and potential biomarkers
-
Invasive lobular carcinoma of the breast: we diagnose it, but do we know what it is?
-
Asbestos exposure diagnosis in pulmonary tissues
-
The 2023 WHO updates on skin tumors: advances since the 2018 edition
Impact Factor 2024
Scopus CiteScore
